CHRISTIE BALLANTYNE to Renal Insufficiency, Chronic
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Renal Insufficiency, Chronic.
Connection Strength
1.537
-
Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome: The ARIC Study. JACC Heart Fail. 2025 Aug; 13(8):102512.
Score: 0.127
-
Alterations in the Circulating Proteome Associated with Albuminuria. J Am Soc Nephrol. 2023 06 01; 34(6):1078-1089.
Score: 0.108
-
Renin: Measurements, Correlates, and Associations With Long-Term Adverse Kidney Outcomes. Am J Hypertens. 2023 01 01; 36(1):42-49.
Score: 0.107
-
Testican-2 Is Associated with Reduced Risk of Incident ESKD. J Am Soc Nephrol. 2023 01 01; 34(1):122-131.
Score: 0.106
-
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD). Clin Cardiol. 2022 Dec; 45(12):1303-1310.
Score: 0.105
-
APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol. 2022 05; 17(5):684-692.
Score: 0.102
-
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2022 02; 36(2):108101.
Score: 0.099
-
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL. Circulation. 2021 11 30; 144(22):1750-1759.
Score: 0.099
-
Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol. 2021 09; 32(9):2291-2302.
Score: 0.098
-
Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD. Am J Kidney Dis. 2022 Mar; 79(3):383-392.
Score: 0.097
-
Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides. Postgrad Med. 2019 Aug; 131(6):390-396.
Score: 0.084
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.081
-
Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease. Kidney Int. 2018 01; 93(1):252-259.
Score: 0.074
-
Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015 Jul; 61(7):938-47.
Score: 0.063
-
Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study. Arterioscler Thromb Vasc Biol. 2014 Aug; 34(8):1770-7.
Score: 0.059
-
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013 Oct 09; 168(4):3741-6.
Score: 0.055
-
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples. Nephrol Dial Transplant. 2012 Jul; 27(7):2839-47.
Score: 0.050
-
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
Score: 0.023